San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
Executive Summary EIA report M/s. Envee Drugs Pvt. Ltd. Survey No. 104, Village: Dumral, Tal: Nadiad, Dist: Kheda, Prepared by San Envirotech Pvt. Ltd. EQMS India Pvt. Ltd. Email: mahendra.sepl@gmail.com Email: eqms@eqmsindia.org EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
Executive Summary E-1 BACKGROUND
Since India is a developing country and industries have always played
major role in the economic development of the country. Gujarat is one
of the well-developed industrialized state, has a significant contribution in industrial as well as economic growth of the country.
M/s. Envee Drugs Pvt. Ltd. is an existing unit located at Survey No. 104, on N.H. No. 8, Village: Dumral, Tal: Nadiad, Dist.: Kheda, Gujarat and is
involved in manufacturing activity of Erythromycin Estolate,
Erythromycin Stearate and Roxithromycin. Unit is now proposed to
expand capacity of existing products with addition of some new
products. Production capacity will be from 0.442 MT/month to 22.175 MT/month after expansion.
The company is located on a plot measuring 8303 m2 for its production
E-2 PROJECT DESCRIPTION Location of Project
M/s. Envee Drugs Pvt. Ltd. is an existing unit at NH-8, Village: Dumral,
Tal: Nadiad, Dist: Kheda, Gujarat. The location of the project site is
given in terms of longitude and latitude. Latitude: 22040’21.62” N Longitude: 72051’11.16” E Site Selection
Unit has been already in existence since long and is familiar with the
surrounding environment; therefore, it becomes easy for the unit to expand the project in the same premises.
The selection of the project site at this location was considered on the availability of the following amenities.
• Availability of suitable and adequate land for the proposed
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
• Availability of infrastructure facilities such as water supply, power,
roads, social infrastructure and man power;
• Good communication and transportation facilities; • Proximity of market; • No R & R will be required; • The nearest city Nadiad is 2.0 km away from the project site,
which is very well connected with other parts of the country by
• No national park or wildlife habitat within 10 km radius of location.
The location of project is best suited for proposed activities. So no
E-3 PROPOSED PRODUCTION CAPACITIES OF PLANT
M/s. Envee Drugs Pvt. Ltd. is involved in manufacturing activity of
Erythromycin Estolate, Erythromycin Stearate and Roxithromycin and now proposed to expand its production capacity with addition of 12 new products. Details of products along with its production capacity is
Detail of the products Name of Product Existing Total Proposed Quantity in Quantity in MT/month MT/Month EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
0.442 22.175 Investment of the project
The cost of the proposed expansion project will be Rs. 1.35 crore. Out of
which, Rs. 22 Lakhs will be utilized for the Environment protection
measures as capital investment and around 3.0 Lakhs as recurring cost
E-4 DESCRIPTION ENVIRONMENT
To predict the impact of the proposed activities on the surrounding environment, the current baseline environmental status was studied by
collecting the data and carrying out monitoring for the period of January-13 to March-13.
The environmental quality has been analyzed with respect to ambient
air quality, water quality, noise levels, soil characteristics, flora & fauna
and parameters concerning human interest. Based on the data, the
relevant impacts on various environmental components were also predicted by using appropriate mathematical models as well as impact
assessment techniques. An appropriate environmental management
plan was also delineated to minimize the adverse impacts.
ENVIRONMENT
The ambient air quality monitoring was carried out at six AAQM
locations, to assess existing sub regional air quality status during winter
season in the month of January-13 to March-13.
Respirable dust sampler along with the analytical methods prescribed by CPCB was used for carrying out air quality monitoring. At all these
sampling locations; PM10, SO2, NOx for 24 hours and NH3 and VOCs were monitored for 8 hours basis to enable the comparison with ambient air
quality standards prescribed by the Central Pollution Control Board.
The data on concentrations of various pollutants were processed for different statistical parameters like arithmetic mean, standard deviation,
minimum and maximum concentration and various percentile values.
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
Particulate Matter (PM10) An average and 98th percentile value of 24-hourly PM10 values at all -the locations ranged between 53.4-71.0 μg/m3 and 63.6-81.3 μg/m3, which
are well within the stipulated standard of CPCB i.e. 100 μg/m3.
Sulphur Dioxide (SO2) An average and 98th percentile value of 24-hourly SO2 value of arithmetic mean at all the locations ranged between 14.0-18.6 μg/m3
and 17.2-21.8 μg/m3 respectively, which are well within the stipulated
Oxides of Nitrogen (NOx) An average and 98th percentile value of 24 hourly NOx value of arithmetic mean at all the locations ranged between 15.8-19.8 μg/m3 and 18.9-23.5 μg/m3 respectively, which are much lower than the
standards i.e. 80 μg/m3, stipulated by CPCB.
E-6 WATER ENVIRONMENT Ground water quality (Primary data) Color: All the samples were found color less meeting desirable norms. pH: All the samples meet the desirable standards (pH ranges from 7.5 Total Dissolved Solids (TDS): TDS in samples ranges from 492 mg/L
(Piplata) to 712 mg/L (Project Site). All the samples meet the
permissible limit of 2000 mg/L, (If alternate sources of potable water are not available).
Calcium: Calcium contents in the water ranges from 14 mg/L (Dumral)
to 27 mg/L (Piplag), all the samples meet the permissible limit of 200
mg/L, (If alternate sources of potable water is not available).
Magnesium: Magnesium content in the water ranges from 21 mg/L
(Dumral) to 32 mg/L (Pij). All the samples meet even the permissible
limit of 100 mg/L (if alternate source of potable water in not available).
Sulfate: Sulfate content in the water ranges from 92 mg/L (Piplata) to
118 mg/L (Project site). All the samples meet the permissible limit of
400 mg/L for drinking water (if alternate source of potable water in not
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
Fluoride: Fluoride content in the water ranges from 0.30 mg/L (Vaso) to 0.48 mg/L (Project site). All the samples meet the desirable limit (1.0 Total Alkalinity: Total alkalinity in the water samples ranges from 312 mg/L (Piplag) to 374 mg/L (Vaso). All the samples are within the
permissible limit of drinking water (600 mg/L) (if alternate source of portable water is not available).
Other Parameters: Potassium (ranges from 12 mg/L to 37 mg/L),
Sodium (ranges from 182 mg/L to 263 mg/L) and Chloride (ranges from
Heavy metals like copper, lead, chromium and zinc are well below the limit in all samples. Conclusions: Ground water samples from villages meet the permissible E-7 NOISE ENVIRONMENT
The Leq values of noise levels during daytime (Ld) varied between 46.6 to 64.4 dB(A). Highest Ld value was recorded near NH-8 (64.4 dB(A)). While the Leq values of noise levels during night time (Ln) varied between 37.0 to 59.7 dB(A). Highest Ln value was recorded on NH-8 (59.7 dB(A)).
E-8 ENVIRONMENTAL IMPACTS AND MITIGATION MEASURES Environment Source of Air Pollution
The main source of emission will be flue gas emission due to combustion
of fuel. At present, there is one flue gas stack of boiler and after
expansion there will be addition of one stack of thermic fluid heater.
Unit is also proposed to install one D.G. set of 50 kVA to fulfill power
requirement in case of non-availability of power/emergency only. Thus,
there will be total three flue stacks after expansion. There will not be
At present LDO/HSD is used as fuel in boiler @400 lit/month and it will
increase up to 2000 lit/month due to increase in overall working hours after expansion. After expansion, LDO @ 4000 Lit/month / HSD @ 3000
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
Lit/month is use as a fuel in TFH. HSD will be used as a fuel in D.G. Set. The most probable emitted flue gas pollutants will be SPM, SO2 and NOx.
Adequate height of chimney will be provided to all the stacks for proper
Air Quality Modelling and Predictions
It is predicted that, the maximum contribution in GLCs, with units operating at full capacity, is 0.897 μg/m3, 0.193 μg/m3, 0.129 μg/m3 for
PM, SO2 and NOx respectively 1 km away from project site (Source) in S direction. With this marginal contribution due to the project, the levels of SPM,
SO2, and NOx will be below the 24–hourly ambient air quality standards for SO2 & NOx (80 μg/m3), PM (100 μg/m3) prescribed by CPCB.
Environment
After expansion, quantity of total water consumption will be increased
up to 19500 lit/day. Out of the total water requirement, 11550 lit/day
will be fresh water and 7950 lit/day condensate water from evaporator, reuse for greenbelt. Fresh Water requirement will be mainly for process,
utilities, washing, domestic purpose and will be fulfilled from existing bore well only.
After expansion, there will be 5650 lit/day of industrial wastewater
generation. Source of wastewater generation will be from process and utilities, RO reject and washing. It will be taken to ETP and after primary
treatment; entire quantity will be evaporated in newly installed evaporator. Condensate from evaporator will be reuse for greenbelt
development. Sewage generation will be 4000 lit/day, which will be
disposed off to soak pit through septic tank. Thus, there will not be any
major impact on the water environment due to proposed project.
Hazardous Waste Management
The entire quantity of hazardous waste will be handled and disposed as
per Hazardous Waste (Management, Handling and Trans boundary
Movement) Rules'2008, amended time to time. After expansion, there
will be total six types of hazardous wastes generation i.e. ETP sludge,
Evaporation residue/salt, spent charcoal, discarded drums/barrels/bags,
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
discarded/off specification drugs and used oil. ETP sludge will be disposed to TSDF site. Evaporation residue/salt will be disposed off to
approve TSDF site, Discarded off specification drugs and spent charcoal
will be incinerated, whereas discarded drums/barrels/bags will be reuse or sold to registered recyclers. Used oil will be disposed by selling to
registered recyclers. The unit will provide isolated area for the storage of hazardous waste.
Thus, hazardous waste management system provided by the unit will be
adequate and there will not be any major impact on the environment
Green Belt Development At present 1200 m2 area is already provided for the green belt and after
proposed expansion it will be extended up to 2740 m2. Thus, total area
provided for the green belt development will be 33% of the total area.
E-9 ENVIRONMENT MONITORING PROGRAM The details of monitoring are as below: Nature of Frequency of analysis Parameters Analysis with its analyzer
Monthly by external agency pH, TDS, SS, Oil &
Stack Monitoring of Monthly by External agency PM, SO2, NOx each stack
Ambient Air Quality Monthly for 24 hours or as
Work zone fugitive Monthly by External agency RPM, VOC
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
E-10 ADDITIONAL STUDIES
Qualitative Analysis
Risk analysis and study have been carried out for identification of
hazards, selection of credible scenarios, Risk Mitigation measures etc.
All the hazardous chemicals will be stored and handled as per MSDS guidelines.
E-11 PROJECT BENEFITS
The proposed project will become beneficial to the surrounding area or community in terms of infrastructural development, Social development,
The proposed project has a potential for employment of skilled, semi-skilled and unskilled employees during construction phase as well as
E-12 ENVIRONMENTAL MANAGEMENT PLAN Overall objective of EMP Prevention: Measures aimed at impeding the occurrence of negative
environmental impacts and/or preventing such an occurrence having
Preservation: Preventing any future actions that might adversely affect Minimization: Limiting or reducing the degree, extent, magnitude, or
EMP for proposed new project of Envee Drugs Pvt. Ltd. covers following
• Description of mitigation measures • Description of monitoring program • Institutional arrangements • Implementation schedule
E-13 CONCLUSION
Based on the study it is concluded that,
• There will be no major impact on water environment as there is no
industrial wastewater discharge. Entire quantity of wastewater will
EIA study for Envee Drugs Pvt. Ltd.
San Envirotech Pvt. Ltd. in association with EQMS India Pvt. Ltd.
be sent to ETP and after primary treatment it will be evaporated in evaporator. Domestic effluent will be disposed through soak pit.
• Unit will use LDO/HSD as a fuel so Air Pollution Control System is
not required as no exceed desire norms laid down by GPCB.
• To prevent Fugitive emission various step will taken like regular
• Adequate arrangement for handling and disposal of Hazardous solid
• Fire protection and safety measures will be provided to take care of
• Suggestions of qualitative risk analysis study will be followed to
minimize accidents and for safe operations.
• Recommendations suggested in Environmental Management Plan
will be followed to minimize the impact of proposed project.
Overall, direct and indirect employment opportunities, improvement in
basic infrastructures by development of industry etc. will be observed with
It can be concluded that on positive implementation of mitigation
measures and environmental management plan during the construction
and operational phase, there will be negligible impact on the environment.
EIA study for Envee Drugs Pvt. Ltd.
Journal of Clinical Pharmacy and Therapeutics (2003) 28, 347–348Optimizing digoxin dosage: the long winding road1A. Li Wan Po* B Pharm PhD and M. J. Kendall MD FRCP*Centre for Evidence-Based Pharmacotherapy, Aston University, Birmingham, UKand Division of Medical Sciences, University of Birmingham, Birmingham, UK‘Conclusions of so much moment to the welfare ofreceiving digoxin were ra
dr. med. steffen heger facharzt für psychosomatische medizin und psychotherapieherbert-lewin-straße 950931 köln-lindenthal veröffentlichungen abstracts S. Heger, J. Büttner, R. Klose, M. Steen, Intraoperative A. Schreiner, S. Heger, Efficacy and tolerability of risperidone Veränderungen des Hämostasesystems bei Brandverletzten, following a switch from different antipsychotics, W